Skip to Content

Join the 'Aggrastat' group to help and get support from people like you.

Aggrastat News

Medicure Announces Approval of Expanded Dosing Time For Aggrastat

Posted 23 Apr 2015 by

WINNIPEG, April 23, 2015 /PRNewswire/ - Medicure Inc. ("Medicure" or the "Company") (TSXV:MPH, OTC:MCUJF), a specialty pharmaceutical company, is pleased to announce that the United States Food and Drug Administration (FDA) has approved a revision to the duration of the bolus delivery for the Aggrastat (tirofiban HCl) high-dose bolus (HDB) regimen. The dosing change and label modification was ...

Ask a Question

Further Information

Related Condition Support Groups

Acute Coronary Syndrome

Aggrastat Patient Information at